Currently, CRC features like tumor stage and grade, lymph node ratio, perineural and lymphovascular invasion, MSI status, tumor budding, circumferential resection margin invasion, tumor regression score, and mutation in KRAS/NRAS and BRAF oncogenes are utilized in treatment strategy and prediction of disease prognosis [2,3]. This evidence concerns the gene NRAS and neoplasm.